Tag Archives: Bipartisan

Biden’s Pick for FDA Gets Bipartisan Support During Hearing

Dec. 14, 2021 — Robert M. Califf, MD, plans to take a detailed take a look at federal insurance policies on opioid prescriptions in his anticipated second flip on the high U.S. regulator of medical merchandise, in addition to hold nearer tabs on the efficiency of medication cleared with accelerated approvals. Califf on Tuesday fielded […]